Former merck usa president joins klotho neurosciences' board of directors

New york, dec. 03, 2024 (globe newswire) -- klotho neurosciences, inc. (nasdaq: klto), a u.s.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related disorders, including als, alzheimer's, and parkinson's, today announced the appointment of riad el-dada, former us president of merck, to its board of directors. with decades of leadership in the pharmaceutical industry, mr.
KLTO Ratings Summary
KLTO Quant Ranking